Alzheimer's drug approved for clinical trial
(Only a handful drug)
Please Help Support Alzheimer's Research Today!
Your Alzheimer's donation will help billions live without it.
An international research consortium led by Trinity College Dublin (Ireland) today announced the selection for funding of a large-scale European clinical trial of Nilvadipine, an Alzheimer’s disease drug developed at the Roskamp Institute in Sarasota. More than 500 Alzheimer’s patients will participate in the multicenter Phase III clinical trial designed to study the effectiveness of Nilvadipine.
“We need many more medicines to move forward into advanced clinical trials in the fight against Alzheimer’s Disease and we are pleased the Roskamp Institute has played such a major role in the development of this drug,” said Michael Mullan, M.D., Ph.D., Roskamp Institute director who, with associate director Fiona Crawford, Ph.D. and lead scientist Daniel Paris, Ph.D., led the research team that developed the drug. Phase III studies are usually the last step in the regulatory process before a drug can move into clinical practice. Continue to read: floridabiotechnews.com
Your brain needs proper diet
Healthy brain aging is a concern for all of us. It's normal to struggle with small things such as recalling names — and we all experience some slowing of the thought processes with advanced age — but everyone hopes to avoid serious cognitive impairment. Read more: kentucky.com
No comments:
Post a Comment